GlassScriptPhysician profile
Richard Franklin
NPI 1962493031
$62,600.20
in general payments reported to CMS, 2019-2025
19 companies · $8,633 in 2025
The $8,633 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,919 · 2020: $7,166 · 2021: $19K · 2022: $5,618 · 2023: $11K · 2024: $1,095 · 2025: $8,633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Travel and Lodging: $3,916 · Consulting Fee: $3,300 · Food and Beverage: $1,944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,675.00 |
| Travel and Lodging | $3,915.58 |
| Consulting Fee | $3,300.00 |
| Food and Beverage | $1,944.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $61,474.47 | 2019-2025 | Collagenase Santyl, Pico, Versajet |
| Keswick Pharmaceuticals LLC | $458.21 | 2019 | |
| Bsn Medical INC | $118.70 | 2024 | |
| Paratek Pharmaceuticals, INC. | $111.38 | 2021-2025 | Nuzyra |
| Hartmann USA, INC. | $53.74 | 2021-2025 | Zetuvit Plus 10x10 P10 |
| Polarityte, INC. | $49.62 | 2019 | |
| Convatec INC. | $42.33 | 2023-2024 | |
| Integra Lifesciences Corporation | $40.72 | 2021 | |
| Kerecis Limited | $36.18 | 2019 | |
| Aroa Biosurgery Incorporated | $35.63 | 2019-2020 | |
| Acell, INC. | $31.09 | 2019 | |
| Osiris Therapeutics INC. | $29.10 | 2019 | |
| Abbvie INC. | $24.88 | 2021 | |
| Melinta Therapeutics, LLC | $18.43 | 2021 | |
| Reprise Biomedical, INC. | $17.87 | 2025 | Miro3d |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $16.16 | 2022 | |
| Merck Sharp & Dohme LLC | $15.04 | 2019 | |
| Cashflow Solutions, LLC | $14.74 | 2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Normatec Industries, LP | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.